{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:55:36Z","timestamp":1794650136551,"version":"4.9.1"},"reference-count":899,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jacc.2024.11.009","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T14:04:59Z","timestamp":1740665099000},"page":"2135-2237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":656,"title":["2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes"],"prefix":"10.1016","volume":"85","author":[{"given":"Sunil V.","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline E.","family":"Tamis-Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio G.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Cruz-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy A.","family":"DeWald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy N.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Isiadinso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Platz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan B.","family":"Promes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yader","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Stopyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam R.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Jneid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Beavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Beckie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Blankenship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Diercks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clauden","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal M.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen T.","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Tomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Welt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.11.009_bib1","series-title":"Finding what works in healthcare: standards for systematic reviews","year":"2011"},{"key":"10.1016\/j.jacc.2024.11.009_bib2","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib3","article-title":"Methodology Manual and Policies From the ACCF\/AHA Task Force on Practice Guidelines","year":"2010","journal-title":"American College of Cardiology and American Heart Association"},{"key":"10.1016\/j.jacc.2024.11.009_bib4","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2014.07.012","volume":"64","author":"Arnett","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib6","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2019.02.012","article-title":"Recent innovations, modifications, and evolution of ACC\/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Levine","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib7","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib8","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib9","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","volume":"67","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib10","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib12","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib14","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jacc.2010.05.008","article-title":"Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention","volume":"56","author":"Roe","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.amjms.2020.02.004","article-title":"Estimating the economic burden of acute myocardial infarction in the US: 12 year national data","volume":"359","author":"Bishu","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jacc.2024.11.009_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011322","article-title":"Acute and 1-year hospitalization costs for acute myocardial infarction treated with percutaneous coronary intervention: results from the TRANSLATE-ACS registry","volume":"8","author":"Cowper","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001197","article-title":"National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010","volume":"3","author":"Chaudhry","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ahj.2015.04.027","article-title":"Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009","volume":"170","author":"Brown","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/clc.22524","article-title":"Racial and ethnic differences in acute coronary syndrome and myocardial infarction within the United States: from demographics to outcomes","volume":"39","author":"Graham","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.117.030564","article-title":"Widening racial differences in risks for coronary heart disease","volume":"137","author":"Nadruz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamacardio.2018.1511","article-title":"Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the Patient and Provider Assessment of Lipid Management Registry","volume":"3","author":"Nanna","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib23","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","article-title":"Racial\/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018","volume":"78","author":"Aggarwal","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.11.009_bib24","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jcin.2020.04.020","article-title":"Prognostic impact of race in patients undergoing PCI: analysis from 10 randomized coronary stent trials","volume":"13","author":"Golomb","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11886-014-0530-3","article-title":"The current state of ethnic and racial disparities in cardiovascular care: lessons from the past and opportunities for the future","volume":"16","author":"Lewey","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib26","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/ATVBAHA.123.319370","article-title":"Sex, racial, and ethnic disparities in acute coronary syndrome: novel risk factors and recommendations for earlier diagnosis to improve outcomes","volume":"43","author":"Khraishah","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2024.11.009_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012307","article-title":"Presenting symptoms in men and women diagnosed with myocardial infarction using sex-specific criteria","volume":"8","author":"Ferry","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.117.031650","article-title":"Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: evidence from the VIRGO study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients)","volume":"137","author":"Lichtman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014733","article-title":"Sex differences in symptom presentation in acute coronary syndromes: a systematic review and meta-analysis","volume":"9","author":"van Oosterhout","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib30","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinte.167.22.2405","article-title":"Symptom presentation of women with acute coronary syndromes: myth vs reality","volume":"167","author":"Canto","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib31","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2018.02.032","article-title":"Sex differences in high-intensity statin use following myocardial infarction in the United States","volume":"71","author":"Peters","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib32","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/eurheartj\/eht368","article-title":"Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010","volume":"34","author":"Koopman","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/CIRCULATIONAHA.118.035550","article-title":"Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016","volume":"139","author":"Peters","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007297","article-title":"Relations of sex to diagnosis and outcomes in acute coronary syndrome","volume":"7","author":"Sorensen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib35","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.jacc.2019.09.065","article-title":"Outcomes of women compared with men after non-ST-segment elevation acute coronary syndromes","volume":"74","author":"Sarma","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib36","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib37","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib39","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib40","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2024.11.009_bib41","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib44","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIR.0000000000000663","article-title":"Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology","volume":"140","author":"Thomas","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib45","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib46","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib47","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","article-title":"Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association","volume":"143","author":"Henry","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib48","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","article-title":"Mechanical complications of acute myocardial infarction: a scientific statement from the American Heart Association","volume":"144","author":"Damluji","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib50","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib51","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1161\/CIR.0000000000001199","article-title":"Cardiac catheterization laboratory management of the comatose adult patient with an out-of-hospital cardiac arrest: a scientific statement from the American Heart Association","volume":"149","author":"Tamis-Holland","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib52","article-title":"Methodology Manual and Policies From the ACCF\/AHA Task Force on Practice Guidelines","year":"2010","journal-title":"American College of Cardiology and American Heart Association"},{"key":"10.1016\/j.jacc.2024.11.009_bib53","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","article-title":"Update on acute coronary syndromes: the pathologists' view","volume":"34","author":"Falk","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib55","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib56","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib57","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib58","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIR.0000000000000564","article-title":"Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association","volume":"137","author":"Hayes","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib59","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib60","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.119.040631","article-title":"Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury","volume":"140","author":"DeFilippis","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib61","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib62","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib63","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2022.08.750","article-title":"2022 ACC expert consensus decision pathway on the evaluation and disposition of acute chest pain in the emergency department: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"80","author":"Kontos","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib64","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1056\/NEJMra022580","article-title":"ST-segment elevation in conditions other than acute myocardial infarction","volume":"349","author":"Wang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023275","article-title":"Rapid diagnosis of stemi equivalent in patients with left bundle-branch block: Is it feasible?","volume":"10","author":"Birnbaum","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1253\/circrep.CR-22-0003","article-title":"Impact of prehospital 12-lead electrocardiography and destination hospital notification on mortality in patients with chest pain- a systematic review","volume":"4","author":"Nakashima","year":"2022","journal-title":"Circ Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib67","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/heartjnl-2013-304599","article-title":"Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project","volume":"100","author":"Quinn","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10903127.2011.614045","article-title":"Serial prehospital 12-lead electrocardiograms increase identification of ST-segment elevation myocardial infarction","volume":"16","author":"Verbeek","year":"2012","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib69","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/10903127.2017.1399185","article-title":"Detection of STEMI using prehospital serial 12-lead electrocardiograms","volume":"22","author":"Tanguay","year":"2018","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcin.2008.11.013","article-title":"Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on door-to-balloon times across 10 independent regions","volume":"2","author":"Rokos","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib71","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/eurheartj\/ehq437","article-title":"Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction","volume":"32","author":"Sorensen","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib72","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacc.2012.07.008","article-title":"Reduction in mortality as a result of direct transport from the field to a receiving center for primary percutaneous coronary intervention","volume":"60","author":"Le May","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.annemergmed.2013.11.016","article-title":"Systematic review and meta-analysis of the benefits of out-of-hospital 12-lead ECG and advance notification in ST-segment elevation myocardial infarction patients","volume":"64","author":"Nam","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib74","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jcin.2018.07.020","volume":"11","author":"Shavadia","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib75","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib76","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCULATIONAHA.117.032446","volume":"137","author":"Jollis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/CIRCULATIONAHA.110.002345","article-title":"Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines","volume":"124","author":"Mathews","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib78","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0196-0644(96)70082-3","article-title":"Incidence of cardiac arrest during self-transport for chest pain","volume":"28","author":"Becker","year":"1996","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib79","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/ajem.2002.35461","article-title":"Predicting a life-threatening disease and death among ambulance-transported patients with chest pain or other symptoms raising suspicion of an acute coronary syndrome","volume":"20","author":"Herlitz","year":"2002","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib80","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/emermed-2014-203780","article-title":"Initial complications and factors related to prehospital mortality in acute myocardial infarction with ST segment elevation","volume":"32","author":"Rosell-Ortiz","year":"2015","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jacc.2024.11.009_bib81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa073102","article-title":"A citywide protocol for primary PCI in ST-segment elevation myocardial infarction","volume":"358","author":"Le May","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1253\/circrep.CR-22-0002","article-title":"Systematic review and meta-analysis of diagnostic accuracy to identify ST-segment elevation myocardial infarction on interpretations of prehospital electrocardiograms","volume":"4","author":"Tanaka","year":"2022","journal-title":"Circ Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib84","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","article-title":"Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib85","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.jacc.2005.12.072","article-title":"Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction","volume":"47","author":"McNamara","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib86","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.annemergmed.2008.08.033","article-title":"Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials","volume":"52","author":"De Luca","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib87","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib88","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0195-668X(02)00468-2","article-title":"Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial PRAGUE-2","volume":"24","author":"Widimsky","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004061","article-title":"Association of rapid care process implementation on reperfusion times across multiple ST-segment-elevation myocardial infarction networks","volume":"10","author":"Fordyce","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib90","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.hlc.2013.11.015","article-title":"Pre-hospital ambulance notification and initiation of treatment of ST elevation myocardial infarction is associated with significant reduction in door-to-balloon time for primary PCI","volume":"23","author":"Savage","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2024.11.009_bib91","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.amjcard.2005.09.073","article-title":"Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative)","volume":"97","author":"Diercks","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib92","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2008.09.030","volume":"53","author":"Diercks","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib93","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ahj.2012.10.027","article-title":"Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program","volume":"165","author":"Riley","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ahj.2014.10.007","article-title":"Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis","volume":"169","author":"Lipinski","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib95","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/CIRCULATIONAHA.120.052380","article-title":"High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial","volume":"143","author":"Anand","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib96","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","article-title":"High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial","volume":"392","author":"Shah","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib97","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Reichlin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib98","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.119.042891","article-title":"A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT)","volume":"140","author":"Chew","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2018.12.001","article-title":"Evaluation of a new ultra-sensitivity troponin I assay in patients with suspected myocardial infarction","volume":"283","author":"Neumann","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib100","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/CIRCULATIONAHA.116.025661","article-title":"Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I","volume":"135","author":"Boeddinghaus","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib101","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jacc.2019.05.046","article-title":"Outcome of applying the ESC 0\/1-hour algorithm in patients with suspected myocardial infarction","volume":"74","author":"Twerenbold","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib102","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/CIRCULATIONAHA.118.034260","article-title":"Direct comparison of the 0\/1h and 0\/3h algorithms for early rule-out of acute myocardial infarction","volume":"137","author":"Badertscher","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib103","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib106","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCOUTCOMES.114.001384","article-title":"The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge","volume":"8","author":"Mahler","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.annemergmed.2016.01.001","article-title":"Effectiveness of EDACS versus ADAPT accelerated diagnostic pathways for chest pain: a pragmatic randomized controlled trial embedded within practice","volume":"68","author":"Than","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib108","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2018.05.040","article-title":"Prospective validation of the 0\/1-h Algorithm for early diagnosis of myocardial infarction","volume":"72","author":"Twerenbold","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib109","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jacc.2017.11.064","article-title":"Performance of coronary risk scores among patients with chest pain in the emergency department","volume":"71","author":"Mark","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib110","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/2012.jama.11348","article-title":"Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction","volume":"308","author":"Puymirat","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib111","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib112","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0735-1097(85)80213-8","article-title":"Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3","volume":"6","author":"Lopez-Sendon","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib113","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1161\/CIRCULATIONAHA.107.185266","article-title":"National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure","volume":"116","author":"Apple","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib114","first-page":"e356","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes","volume":"115","author":"Morrow","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib115","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jacc.2013.02.078","article-title":"Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome","volume":"62","author":"Cullen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib116","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2017.07.746","article-title":"Effect of the FDA regulatory approach on the 0\/1-h algorithm for rapid diagnosis of MI","volume":"70","author":"Twerenbold","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib117","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/heartjnl-2019-316343","article-title":"Safety and efficacy of the European Society of Cardiology 0\/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis","volume":"106","author":"Chiang","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib118","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archinternmed.2012.3698","article-title":"One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T","volume":"172","author":"Reichlin","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib119","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/CIRCULATIONAHA.120.049298","article-title":"Diagnostic performance of high-sensitivity cardiac troponin T strategies and clinical variables in a multisite US cohort","volume":"143","author":"Allen","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2023.0043","article-title":"Critical appraisal of the negative predictive performance of the European Society of Cardiology 0\/1-hour algorithm for evaluating patients with chest pain in the US","volume":"8","author":"Karady","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib121","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMoa0903515","article-title":"Sensitive troponin I assay in early diagnosis of acute myocardial infarction","volume":"361","author":"Keller","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib122","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.122.059678","article-title":"High-sensitivity cardiac troponin and the 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guidelines for the evaluation and diagnosis of acute chest pain","volume":"146","author":"Sandoval","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib123","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0002-8703(03)00455-1","article-title":"Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction","volume":"146","author":"Brilakis","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib124","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157340311795677662","article-title":"Risk scores for patients with chest pain: evaluation in the emergency department","volume":"7","author":"Backus","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jacc.2024.11.009_bib125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/hrt.2008.144022","article-title":"Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database","volume":"95","author":"Gale","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib126","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib127","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib128","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib129","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score","volume":"4","author":"Fox","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2024.11.009_bib130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/CIRCOUTCOMES.111.000072","article-title":"Perceived risk of ischemic and bleeding events in acute coronary syndromes","volume":"6","author":"Chew","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib131","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamacardio.2020.6314","article-title":"Objective risk assessment vs standard care for acute coronary syndromes: a randomized clinical trial","volume":"6","author":"Chew","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib132","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073843","article-title":"Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial","volume":"381","author":"Gale","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib133","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(67)90023-9","article-title":"Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients","volume":"20","author":"Killip","year":"1967","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib134","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010269","article-title":"Admission bedside lung ultrasound reclassifies mortality prediction in patients with ST-segment-elevation myocardial infarction","volume":"13","author":"Araujo","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.009_bib135","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/echo.15262","article-title":"Prevalence and prognostic importance of lung ultrasound findings in acute coronary syndrome: a systematic review","volume":"38","author":"Lindner","year":"2021","journal-title":"Echocardiography"},{"key":"10.1016\/j.jacc.2024.11.009_bib136","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ahj.2013.11.005","article-title":"Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction","volume":"167","author":"van Diepen","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib137","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/eurheartj\/ehn062","article-title":"Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and\/or left ventricular dysfunction: a VALIANT study","volume":"29","author":"Lewis","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib138","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa1803377","article-title":"Application of High-sensitivity troponin in suspected myocardial infarction","volume":"380","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib139","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1056\/NEJMoa013456","article-title":"Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction","volume":"346","author":"Aviles","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib140","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","article-title":"Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib141","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/eurheartj\/ehq468","article-title":"Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial","volume":"32","author":"Scirica","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib142","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010259","article-title":"Prognostic importance of NT-proBNP (N-terminal pro-B-type natriuretic peptide) following high-risk myocardial infarction in the PARADISE-MI trial","volume":"16","author":"Jering","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.009_bib143","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.jacc.2018.07.074","article-title":"Cardiac shock care centers: JACC review topic of the week","volume":"72","author":"Rab","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib144","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","article-title":"Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association","volume":"143","author":"Henry","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib146","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/cc11516","article-title":"Choice of hospital after out-of-hospital cardiac arrest-a decision with far-reaching consequences: a study in a large German city","volume":"16","author":"Wnent","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib147","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003414","article-title":"Direct transport to a percutaneous cardiac intervention center and outcomes in patients with out-of-hospital cardiac arrest","volume":"10","author":"Kragholm","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib148","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.resuscitation.2006.07.013","article-title":"Acute ST-elevation myocardial infarction after successful cardiopulmonary resuscitation","volume":"72","author":"Gorjup","year":"2007","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2024.11.009_bib149","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcin.2022.03.035","article-title":"MIRACLE(2) score and SCAI grade to identify patients with out-of-hospital cardiac arrest for immediate coronary angiography","volume":"15","author":"Pareek","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib150","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.106.657619","article-title":"Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction","volume":"115","author":"Garot","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib151","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2008.08.076","article-title":"Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest","volume":"53","author":"Hosmane","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib152","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcin.2017.09.011","article-title":"Should we perform an immediate coronary angiogram in all patients after cardiac arrest?: Insights from a large French registry","volume":"11","author":"Bougouin","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib153","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamacardio.2020.3670","article-title":"Coronary angiography after cardiac arrest without ST segment elevation: one-year outcomes of the COACT randomized clinical trial","volume":"5","author":"Lemkes","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib154","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.120.049569","article-title":"Randomized pilot clinical trial of early coronary angiography versus no early coronary angiography after cardiac arrest without ST-segment elevation: the PEARL study","volume":"142","author":"Kern","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib155","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa2101909","article-title":"Angiography after out-of-hospital cardiac arrest without ST-segment elevation","volume":"385","author":"Desch","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib156","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamacardio.2022.1416","article-title":"Emergency vs delayed coronary angiogram in survivors of out-of-hospital cardiac arrest: results of the randomized, multicentric EMERGE trial","volume":"7","author":"Hauw-Berlemont","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib157","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.resuscitation.2019.04.027","article-title":"Direct or subacute coronary angiography in out-of-hospital cardiac arrest (DISCO)-An initial pilot-study of a randomized clinical trial","volume":"139","author":"Elfwen","year":"2019","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2024.11.009_bib158","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.recesp.2022.05.004","article-title":"Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial","volume":"76","author":"Viana-Tejedor","year":"2023","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacc.2024.11.009_bib159","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa1816897","article-title":"Coronary angiography after cardiac arrest without ST-segment elevation","volume":"380","author":"Lemkes","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005717","article-title":"Improvement in care and outcomes for emergency medical service-transported patients with ST-elevation myocardial infarction (STEMI) with and without prehospital cardiac arrest: a Mission: Lifeline STEMI Accelerator study","volume":"6","author":"Kragholm","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib161","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(18)30472-0","article-title":"Out-of-hospital cardiac arrest: current concepts","volume":"391","author":"Myat","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib162","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jcin.2015.02.021","article-title":"Outcomes of comatose cardiac arrest survivors with and without ST-segment elevation myocardial infarction: importance of coronary angiography","volume":"8","author":"Kern","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib163","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","article-title":"Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association","volume":"143","author":"Henry","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib164","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1161\/CIR.0000000000001199","article-title":"Cardiac catheterization laboratory management of the comatose adult patient with an out-of-hospital cardiac arrest: a scientific statement from the American Heart Association","volume":"149","author":"Tamis-Holland","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib165","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(23)01351-X","article-title":"Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST): a UK prospective, multicentre, parallel, randomised clinical trial","volume":"402","author":"Patterson","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib166","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1093\/eurheartj\/ehl335","article-title":"Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score","volume":"27","author":"Adrie","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib167","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.amjmed.2020.03.046","article-title":"Usefulness of the NULL-PLEASE score to predict survival in Out-of-Hospital Cardiac Arrest (OCHA)","volume":"133","author":"Gue","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib168","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.resuscitation.2019.05.028","article-title":"External validation of a risk classification at the emergency department of post-cardiac arrest syndrome patients undergoing targeted temperature management","volume":"140","author":"Nishikimi","year":"2019","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2024.11.009_bib169","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13054-017-1677-2","article-title":"Early predictors of poor outcome after out-of-hospital cardiac arrest","volume":"21","author":"Martinell","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacc.2015.05.009","article-title":"Cardiac arrest","volume":"66","author":"Rab","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib171","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jacc.2020.11.043","article-title":"Risk stratification among survivors of cardiac arrest considered for coronary angiography","volume":"77","author":"Harhash","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib172","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehv556","article-title":"The CAHP (Cardiac Arrest Hospital Prognosis) score: a tool for risk stratification after out-of-hospital cardiac arrest","volume":"37","author":"Maupain","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib173","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcin.2017.09.011","article-title":"Should we perform an immediate coronary angiogram in all patients after cardiac arrest?","volume":"11","author":"Bougouin","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib174","first-page":"844","article-title":"SCAI expert consensus statement on out of hospital cardiac arrest","volume":"96","author":"Lotfi","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib175","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib176","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.amjcard.2022.04.015","article-title":"Meta-analysis of early versus delayed or selective coronary angiography in patients with out-of-hospital cardiac arrest without ST-elevation myocardial infarction","volume":"175","author":"Bavishi","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib177","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0002-9149(69)90474-3","article-title":"Correcting arterial hypoxemia by oxygen therapy in patients with acute myocardial infarction. Effect on ventilation and hemodynamics","volume":"24","author":"Sukumalchantra","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib178","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1706222","article-title":"Oxygen therapy in suspected acute myocardial infarction","volume":"377","author":"Hofmann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib179","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.114.014494","article-title":"Air versus oxygen in ST-segment-elevation myocardial infarction","volume":"131","author":"Stub","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MEJ.0000000000000431","article-title":"Effect of oxygen therapy on myocardial salvage in ST elevation myocardial infarction: the randomized SOCCER trial","volume":"25","author":"Khoshnood","year":"2018","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib181","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/014107680710000311","article-title":"Oxygen therapy in myocardial infarction: an historical perspective","volume":"100","author":"Beasley","year":"2007","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib182","article-title":"High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial","volume":"372","author":"Stewart","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.jacc.2024.11.009_bib183","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(18)30479-3","article-title":"Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis","volume":"391","author":"Chu","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib184","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.21037\/atm-20-2614","article-title":"Admission oxygen saturation and all-cause in-hospital mortality in acute myocardial infarction patients: data from the MIMIC-III database","volume":"8","author":"Yu","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib185","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1093\/eurheartj\/ehy326","article-title":"Oxygen therapy in ST-elevation myocardial infarction","volume":"39","author":"Hofmann","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib186","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcin.2019.09.016","article-title":"Effect of oxygen therapy on cardiovascular outcomes in relation to baseline oxygen saturation","volume":"13","author":"James","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib187","first-page":"1115","article-title":"GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib188","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib189","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000006782","article-title":"Pain scoring-a method for assessing acute antianginal therapy comparison of the response to acute sublingual administration of an isosorbide dinitrate tablet, isosorbide dinitrate spray and nitroglycerin spray in unstable angina","volume":"89","author":"Shotan","year":"1998","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2024.11.009_bib190","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/10903127.2018.1558318","article-title":"Safety and effectiveness of field nitroglycerin in patients with suspected ST elevation myocardial infarction","volume":"23","author":"Bosson","year":"2019","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib191","first-page":"277","article-title":"Chest pain relief in patients with acute myocardial infarction","volume":"5","author":"Parodi","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib192","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib193","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/eurheartj\/ehv547","article-title":"Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial","volume":"37","author":"Kubica","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib194","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0038-1666862","article-title":"Fentanyl delays the platelet inhibition effects of oral ticagrelor: full report of the PACIFY randomized clinical trial","volume":"118","author":"Ibrahim","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2024.11.009_bib195","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacc.2013.10.068","article-title":"Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Hobl","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib196","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1160\/TH16-02-0102","article-title":"Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction","volume":"116","author":"Thomas","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2024.11.009_bib197","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40256-018-0305-0","article-title":"Morphine and ticagrelor interaction in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: ATLANTIC-Morphine","volume":"19","author":"Lapostolle","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2024.11.009_bib198","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jacc.2019.11.035","article-title":"Morphine and cardiovascular outcomes among patients with non-ST-segment elevation acute coronary syndromes undergoing coronary angiography","volume":"75","author":"Furtado","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib199","first-page":"76","article-title":"Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: systematic review and meta-analysis","volume":"96","author":"Batchelor","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajem.2023.05.010","article-title":"Effects of morphine and P2Y inhibitor amongst patients with acute coronary syndrome: a meta-analysis of comparative studies","volume":"70","author":"Lee","year":"2023","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib201","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv505","article-title":"Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology","volume":"37","author":"Schmidt","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib202","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/CIRCULATIONAHA.110.004671","article-title":"Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study","volume":"123","author":"Schjerning Olsen","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib203","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib204","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","article-title":"Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis","volume":"330","author":"Hippisley-Cox","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib205","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association","volume":"115","author":"Antman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib206","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.101.9.955","article-title":"Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty","volume":"101","author":"Doucet","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib207","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2796.1998.00253.x","article-title":"Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study","volume":"243","author":"Karlberg","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006743.pub2","article-title":"Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event","author":"Perez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2024.11.009_bib209","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2003.09.023","article-title":"Time course of the interaction between tadalafil and nitrates","volume":"42","author":"Kloner","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib210","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/01.CCM.0000269371.70738.30","article-title":"Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial","volume":"35","author":"Parker","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib211","article-title":"Hemodynamic effect of avanafil and glyceryl trinitrate coadministration","volume":"2013","author":"Swearingen","year":"2013","journal-title":"Drugs Context"},{"key":"10.1016\/j.jacc.2024.11.009_bib212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib213","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib214","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib215","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Current Oasis Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib216","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2102137","article-title":"Comparative effectiveness of aspirin dosing in cardiovascular disease","volume":"384","author":"Jones","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib217","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib218","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1001\/jama.292.24.3017","article-title":"Aspirin sensitivity: implications for patients with coronary artery disease","volume":"292","author":"Gollapudi","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib219","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s11239-023-02782-1","article-title":"Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease","volume":"55","author":"Cortellini","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2024.11.009_bib220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2019.03.047","article-title":"Meta-analysis of acetylsalicylic acid desensitization in patients with acute coronary syndrome","volume":"124","author":"Chopra","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib221","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib222","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib223","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib224","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib225","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib226","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib227","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib228","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib229","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d3527","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"342","author":"James","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib230","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib231","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib232","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib233","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib234","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib236","first-page":"e600","article-title":"Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?","volume":"114","author":"O'Donoghue","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib237","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib238","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib239","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib240","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib241","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib242","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib243","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2018.3197","article-title":"Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial","volume":"319","author":"Zhao","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib244","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Sch\u00fcpke","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib245","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(20)30325-1","article-title":"Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial","volume":"395","author":"Gimbel","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib246","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes","volume":"369","author":"Montalescot","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib247","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib248","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcin.2023.10.064","article-title":"Pretreatment with P2Y(12) inhibitors in ST-segment elevation myocardial infarction: insights from the Bern-PCI registry","volume":"17","author":"Rohla","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib249","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2012.50788","article-title":"Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"308","author":"Bellemain-Appaix","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2018.0612","article-title":"Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a randomized clinical trial","volume":"3","author":"Berwanger","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib251","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib252","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib253","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib254","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data","volume":"382","author":"Steg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib255","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib256","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0091270009344986","article-title":"Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist","volume":"50","author":"Akers","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2024.11.009_bib257","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib259","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.2012.421","article-title":"Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial","volume":"307","author":"Stone","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib260","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(11)61872-2","article-title":"Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial","volume":"379","author":"Thiele","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib261","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib262","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib263","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","article-title":"Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction","volume":"365","author":"Kastrati","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib264","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib265","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/01.CIR.100.15.1609","volume":"100","author":"Zhao","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib266","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/CIRCINTERVENTIONS.111.961425","article-title":"Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study","volume":"5","author":"Ohlmann","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib267","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2018.03.007","article-title":"A randomized double-blind placebo-controlled study comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing transradial rescue percutaneous coronary intervention after failed thrombolysis","volume":"122","author":"Bertrand","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib268","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12928-016-0418-9","article-title":"Intracoronary versus intravenous eptifibatide during percutaneous coronary intervention for acute ST-segment elevation myocardial infarction; a randomized controlled trial","volume":"32","author":"Sanati","year":"2017","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jacc.2024.11.009_bib269","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib270","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib271","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib272","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib273","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib274","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib275","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2010.1320","article-title":"Futura Oasis Trial Group. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA\/OASIS-8 randomized trial","volume":"304","author":"Steg","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib276","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/eurheartj\/ehm224","article-title":"Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis","volume":"28","author":"Murphy","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib277","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib278","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/01.CIR.0000013402.34759.46","article-title":"Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial","volume":"105","author":"Antman","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib279","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa060898","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction","volume":"354","author":"Antman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib280","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib281","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/01.CIR.91.7.1929","article-title":"Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes","volume":"91","author":"Granger","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib282","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0735-1097(01)01143-3","article-title":"Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes","volume":"37","author":"Bahit","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib283","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib284","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(22)01999-7","article-title":"Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial","volume":"400","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib285","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(14)61216-2","article-title":"Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials","volume":"384","author":"Cavender","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib286","article-title":"Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors","volume":"349","author":"Bangalore","year":"2014","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.jacc.2024.11.009_bib287","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"Steg","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib288","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jama.2015.2323","article-title":"Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial","volume":"313","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib289","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(07)60450-4","article-title":"Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial","volume":"369","author":"Stone","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib290","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","article-title":"Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction","volume":"365","author":"Kastrati","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib291","first-page":"1240","article-title":"Meta-analysis of bivalirudin versus heparin in transradial coronary interventions","volume":"96","author":"Kheiri","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib292","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/CIRCULATIONAHA.123.063946","article-title":"Bivalirudin versus heparin during PCI in NSTEMI: individual patient data meta-analysis of large randomized trials","volume":"148","author":"Bikdeli","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib293","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(11)60876-3","article-title":"Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial","volume":"378","author":"Montalescot","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib294","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.amjcard.2013.07.003","article-title":"A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)","volume":"112","author":"Collet","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib295","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e553","article-title":"Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis","volume":"344","author":"Silvain","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib296","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib297","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/hc3101.093866","article-title":"Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)","volume":"104","author":"Ross","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib298","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(01)05775-0","article-title":"Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib299","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/eurheartj\/ehm616","article-title":"The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial","volume":"29","author":"Peters","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib300","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib301","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib302","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1093\/eurheartj\/ehw061","article-title":"Anticoagulation in coronary intervention","volume":"37","author":"Zeymer","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib303","first-page":"611","article-title":"The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results","volume":"15","author":"Mahaffey","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib304","first-page":"177","article-title":"Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia","volume":"57","author":"Lewis","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib305","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib306","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002044","article-title":"Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA\/OASIS-8 Trial","volume":"8","author":"Ducrocq","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib307","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.008969","article-title":"Bivalirudin versus heparin monotherapy in ST-segment-elevation myocardial infarction","volume":"14","author":"James","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib308","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221077973","article-title":"Safety of bivalirudin combined with ticagrelor in the emergency PCI in patients with acute ST-segment elevation myocardial infarction","volume":"28","author":"Wang","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2024.11.009_bib309","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcin.2014.10.003","article-title":"Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb\/IIIa inhibitors in patients with acute coronary syndrome","volume":"8","author":"Navarese","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib310","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib311","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1507854","article-title":"Bivalirudin or unfractionated heparin in acute coronary syndromes","volume":"373","author":"Valgimigli","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib312","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib313","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/eurheartj\/ehm179","article-title":"Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis","volume":"28","author":"Giraldez","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib314","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1161\/CIRCULATIONAHA.105.573550","article-title":"Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials","volume":"112","author":"Eikelboom","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib315","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib316","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib317","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib318","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib319","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib320","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib321","first-page":"787","article-title":"Evolocumab in patients with cardiovascular disease","volume":"377","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib322","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jacl.2015.08.006","article-title":"Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: the ODYSSEY ALTERNATIVE randomized trial","volume":"9","author":"Moriarty","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacc.2024.11.009_bib323","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2016.3608","article-title":"Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib324","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib325","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib326","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.120.049447","article-title":"Clinical efficacy and safety of alirocumab after acute coronary syndrome according to achieved level of low-density lipoprotein cholesterol: a propensity score-matched analysis of the ODYSSEY OUTCOMES trial","volume":"143","author":"Schwartz","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib327","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","article-title":"Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy","volume":"46","author":"Wiviott","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib328","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib329","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1038\/s41598-023-30597-w","article-title":"Incidence and predictors of cardiovascular outcomes after acute coronary syndrome in a population-based cohort study","volume":"13","author":"Ulvenstam","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib330","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022198","article-title":"Event rates and risk factors for recurrent cardiovascular events and mortality in a contemporary post acute coronary syndrome population representing 239,234 patients during 2005 to 2018 in the United States","volume":"11","author":"Steen","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib331","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Cholesterol Treatment Trialists Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib332","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1373\/clinchem.2010.145631","article-title":"Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review","volume":"56","author":"Barth","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2024.11.009_bib333","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.amjcard.2007.04.053","article-title":"Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)","volume":"100","author":"Murphy","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib334","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamacardio.2020.0882","article-title":"Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: a prespecified secondary analysis from the FOURIER trial","volume":"5","author":"Gencer","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib335","first-page":"1542","article-title":"Alirocumab and cardiovascular outcomes in patients with previous myocardial infarction: prespecified subanalysis from ODYSSEY OUTCOMES","volume":"38","author":"Chiang","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib336","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)","volume":"74","author":"Koskinas","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib337","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.120.046320","article-title":"Effect of evolocumab on atherogenic lipoproteins during the peri- and early postinfarction period: a placebo-controlled, randomized trial","volume":"142","author":"Leucker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib338","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.009_bib339","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"Raber","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib340","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib341","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"Bytyci","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib342","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacl.2022.05.068","article-title":"NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient","volume":"16","author":"Cheeley","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacc.2024.11.009_bib343","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1803917","article-title":"Safety and efficacy of bempedoic acid to reduce LDL cholesterol","volume":"380","author":"Ray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib344","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1001\/jama.2019.16585","article-title":"Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients at high risk for cardiovascular disease: the CLEAR Wisdom randomized clinical trial","volume":"322","author":"Goldberg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib345","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/2047487319864671","article-title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","volume":"27","author":"Ballantyne","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib346","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jacc.2021.08.011","article-title":"Baseline low-density lipoprotein cholesterol and clinical outcomes of combining ezetimibe with statin therapy in IMPROVE-IT","volume":"78","author":"Oyama","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib347","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.122.061620","article-title":"Long-term evolocumab in patients with established atherosclerotic cardiovascular disease","volume":"146","author":"O'Donoghue","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib348","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","article-title":"Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)","volume":"137","author":"Giugliano","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib349","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jacc.2016.11.070","article-title":"Atherothrombotic risk stratification and ezetimibe for secondary prevention","volume":"69","author":"Bohula","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib350","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11883-023-01084-4","article-title":"Benefit of combination ezetimibe\/simvastatin among high-risk populations: lessons from the IMPROVE-IT trial","volume":"25","author":"Oliver","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib351","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/CIRCULATIONAHA.118.034309","article-title":"Clinical benefit of evolocumab by severity and extent of coronary artery disease: analysis from FOURIER","volume":"138","author":"Sabatine","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib352","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib353","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jacc.2019.03.013","article-title":"Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial","volume":"74","author":"Jukema","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib354","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.119.042551","article-title":"Risk categorization using New American College of Cardiology\/American Heart Association Guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes","volume":"140","author":"Roe","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib355","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.121.054663","article-title":"Combining high-sensitivity troponin with the American Heart Association\/American College of Cardiology cholesterol guidelines to guide evolocumab therapy","volume":"144","author":"Marston","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib356","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib357","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib358","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib359","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib360","first-page":"284","article-title":"A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure","volume":"67","author":"de Peuter","year":"2009","journal-title":"Neth J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib361","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ehjcvp\/pvy034","article-title":"Effect of oral beta-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis","volume":"5","author":"Dahl Aarvik","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2024.11.009_bib362","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2011.01.006","article-title":"Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology's NCDR","volume":"161","author":"Kontos","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib363","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib364","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199347","article-title":"Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"13","author":"Watanabe","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2024.11.009_bib365","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention","volume":"67","author":"Roolvink","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib366","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib367","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib368","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting\u2013enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib369","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting\u2013enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib370","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib371","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib372","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib373","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib374","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib375","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib376","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor-neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib377","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the randomized double-blind REMINDER study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib378","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamacardio.2016.5977","article-title":"A system of care for patients with ST-segment elevation myocardial infarction in India: the Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program","volume":"2","author":"Alexander","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib379","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4244\/AIJ-D-17-00048","article-title":"Hospital outcomes in STEMI patients after the introduction of a regional STEMI network in the metropolitan area of a developing country","volume":"4","author":"Dharma","year":"2018","journal-title":"AsiaIntervention"},{"key":"10.1016\/j.jacc.2024.11.009_bib380","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008624","article-title":"Implementation of a regional network for ST-segment-elevation myocardial infarction (STEMI) care and 30-day mortality in a low- to middle-income city in Brazil: findings from Salvador's STEMI registry (RESISST)","volume":"7","author":"Filgueiras Filho","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib381","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.115.019474","article-title":"Regional systems of care demonstration project: American Heart Association Mission: Lifeline STEMI Systems Accelerator","volume":"134","author":"Jollis","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib382","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCULATIONAHA.117.032446","volume":"137","author":"Jollis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib383","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","article-title":"Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015","volume":"136","author":"Puymirat","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib384","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1161\/CIR.0000000000001025","article-title":"Systems of care for ST-segment\u2013elevation myocardial infarction: a policy statement from the American Heart Association","volume":"144","author":"Jacobs","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib385","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/jama.2022.20149","article-title":"Treatment time and in-hospital mortality among patients with ST-segment elevation myocardial infarction, 2018-2021","volume":"328","author":"Jollis","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib386","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.jacc.2005.12.072","article-title":"Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction","volume":"47","author":"McNamara","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib387","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","article-title":"Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib388","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.CIR.100.1.14","article-title":"Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial","volume":"100","author":"Berger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib389","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1208200","article-title":"Door-to-balloon time and mortality among patients undergoing primary PCI","volume":"369","author":"Menees","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib390","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199706053362301","article-title":"A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib391","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib392","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199911043411901","article-title":"Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction","volume":"341","author":"Zijlstra","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib393","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehy004","article-title":"Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial","volume":"39","author":"Scholz","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib394","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib395","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/ejcts\/ezv388","article-title":"Is emergency and salvage coronary artery bypass grafting justified? The Nordic emergency\/salvage coronary artery bypass grafting study","volume":"49","author":"Axelsson","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib396","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012049","article-title":"Early clinical outcomes of surgical myocardial revascularization for acute coronary syndromes complicated by cardiogenic shock: a report from the North-Rhine-Westphalia Surgical Myocardial Infarction Registry","volume":"8","author":"Liakopoulos","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib397","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1001\/jama.293.23.2865","article-title":"Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial","volume":"293","author":"Sch\u00f6mig","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib398","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjcard.2010.10.008","article-title":"Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS])","volume":"107","author":"Gierlotka","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib399","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.2009.32","article-title":"Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms","volume":"301","author":"Ndrepepa","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib400","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jacc.2021.07.039","article-title":"Percutaneous myocardial revascularization in late-presenting patients with STEMI","volume":"78","author":"Bouisset","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib401","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa066139","article-title":"Coronary intervention for persistent occlusion after myocardial infarction","volume":"355","author":"Hochman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib402","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.ehj.2004.10.019","article-title":"DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction","volume":"25","author":"Steg","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib403","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib404","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007195","article-title":"Association of cardiac care regionalization with access, treatment, and mortality among patients with ST-segment elevation myocardial infarction","volume":"14","author":"Shen","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib405","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCULATIONAHA.117.032446","volume":"137","author":"Jollis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib406","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCULATIONAHA.117.032446","article-title":"Impact of regionalization of ST-segment\u2013elevation myocardial infarction care on treatment times and outcomes for emergency medical services: transported patients presenting to hospitals with percutaneous coronary intervention","volume":"137","author":"Jollis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib407","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/CIRCULATIONAHA.111.044107","article-title":"Improvements in door-to-balloon time in the United States, 2005 to 2010","volume":"124","author":"Krumholz","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib408","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib409","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.amjcard.2020.11.016","article-title":"Meta-analysis of transradial vs transfemoral access for percutaneous coronary intervention in patients with ST elevation myocardial infarction","volume":"141","author":"Jhand","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib410","first-page":"510","article-title":"Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: a prespecified subgroup analysis from VALIDATE-SWEDEHEART","volume":"8","author":"V\u00f6lz","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib411","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","article-title":"One-year survival following early revascularization for cardiogenic shock","volume":"285","author":"Hochman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib412","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib413","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ahj.2020.01.020","article-title":"Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock","volume":"226","author":"Smilowitz","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib414","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.111.041749","article-title":"Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction","volume":"124","author":"Hochman","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib415","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003490","volume":"10","author":"Pi","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib416","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005498","article-title":"Outcome of stable patients with acute myocardial infarction and coronary artery bypass surgery within 48 hours: a single-center, retrospective experience","volume":"6","author":"Grothusen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib417","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib418","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020517","article-title":"Temporal trends, clinical characteristics, and outcomes of emergent coronary artery bypass grafting for acute myocardial infarction in the United States","volume":"10","author":"Patlolla","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib419","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021182","article-title":"Coronary artery bypass graft surgery in patients with acute coronary syndromes after primary percutaneous coronary intervention: a current report from the North-Rhine Westphalia Surgical Myocardial Infarction Registry","volume":"10","author":"Thielmann","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib420","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjcard.2011.05.007","article-title":"System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial)","volume":"108","author":"Nielsen","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib421","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.0000091088.63921.8C","article-title":"Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis","volume":"108","author":"Dalby","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib422","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026700","article-title":"Emergency interhospital transfer of patients with ST-segment-elevation myocardial infarction: call 9-1-1-the American Heart Association Mission: Lifeline Program","volume":"11","author":"French","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib423","article-title":"Reperfusion strategy of ST-elevation myocardial infarction: a meta-analysis of primary percutaneous coronary intervention and pharmaco-invasive therapy","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib424","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015186","article-title":"Comparison of reperfusion strategies for ST-segment-elevation myocardial infarction: a multivariate network meta-analysis","volume":"9","author":"Fazel","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib425","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.amjcard.2016.03.036","article-title":"Pharmacoinvasive and primary percutaneous coronary intervention strategies in ST-elevation myocardial infarction (from the Mayo Clinic STEMI Network)","volume":"117","author":"Siontis","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib426","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib427","first-page":"397","article-title":"Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)","volume":"1","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib428","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib429","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction","volume":"368","author":"Armstrong","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib430","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1001\/jama.293.23.2865","article-title":"Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial","volume":"293","author":"Sch\u00f6mig","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib431","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjcard.2010.10.008","article-title":"Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS])","volume":"107","author":"Gierlotka","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib432","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib433","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2012.10.032","article-title":"Enhancing the efficacy of delivering reperfusion therapy: a European and North American experience with ST-segment elevation myocardial infarction networks","volume":"165","author":"Huber","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib434","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1475-6773.12335","article-title":"Percutaneous coronary intervention in the United States: risk factors for untimely access","volume":"51","author":"Hsia","year":"2016","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jacc.2024.11.009_bib435","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.105.596346","article-title":"Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction","volume":"113","author":"Nallamothu","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib436","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.112.000836","article-title":"Expansion of invasive cardiac services in the United States","volume":"128","author":"Horwitz","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib437","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib438","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/CIRCULATIONAHA.111.018549","article-title":"Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase","volume":"124","author":"Pinto","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib439","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1253\/circrep.CR-21-0160","article-title":"Effects of door-in to door-out time on mortality among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention - systematic review and meta-analysis","volume":"4","author":"Yamaguchi","year":"2022","journal-title":"Circ Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib440","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12873-020-00355-6","article-title":"Breaking down walls: a qualitative evaluation of perceived emergency department delays for patients transferred with ST-elevation myocardial infarction","volume":"20","author":"Ward","year":"2020","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib441","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.114.009570","article-title":"ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up","volume":"130","author":"Sinnaeve","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib442","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5482\/HAMO-13-07-0040","article-title":"Fibrinolytic treatment of ST-elevation myocardial infarction. Update 2014","volume":"34","author":"Halvorsen","year":"2014","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jacc.2024.11.009_bib443","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.hjc.2019.01.001","article-title":"Challenges and unanswered questions in STEMI management","volume":"60","author":"Koutsoukis","year":"2019","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib444","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/heartjnl-2014-306686","article-title":"Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged","volume":"101","author":"Gershlick","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib445","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.amjcard.2018.04.057","article-title":"Meta-analysis comparing primary percutaneous coronary intervention versus pharmacoinvasive therapy in transfer patients with ST-elevation myocardial infarction","volume":"122","author":"Siddiqi","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib446","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015186","article-title":"Comparison of reperfusion strategies for ST-segment-elevation myocardial infarction: a multivariate network meta-analysis","volume":"9","author":"Fazel","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib447","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008059","article-title":"Pharmacoinvasive strategy versus primary percutaneous coronary intervention in ST-elevation myocardial infarction in clinical practice: insights from the Vital Heart Response Registry","volume":"12","author":"Bainey","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib448","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.114.009570","article-title":"ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up","volume":"130","author":"Sinnaeve","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib449","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib450","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0140-6736(93)91538-W","article-title":"Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib451","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0735-1097(96)00012-5","article-title":"Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)","volume":"27","author":"Langer","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib452","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.CIR.94.5.891","volume":"94","author":"Bode","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib453","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1161\/01.CIR.103.23.2862","article-title":"Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1","volume":"103","author":"Armstrong","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib454","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0735-1097(92)90265-O","article-title":"Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)","volume":"19","author":"Neuhaus","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib455","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.95.2.351","article-title":"TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial","volume":"95","author":"Cannon","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib456","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(17)31441-1","article-title":"Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis","volume":"390","author":"Jinatongthai","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib457","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajem.2022.05.021","article-title":"Comparison of tenecteplase versus alteplase in STEMI patients treated with ticagrelor: a cross-sectional study","volume":"58","author":"G\u00fcnl\u00fc","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib458","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","article-title":"Assessment of the Safety Efficacy of a New Thrombolytic Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial","volume":"354","author":"Van De Werf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib459","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","article-title":"A comparison of reteplase with alteplase for acute myocardial infarction","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib460","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(03)00763-0","article-title":"Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction","volume":"42","author":"Scheller","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib461","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2005.04.042","article-title":"Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study)","volume":"46","author":"Le May","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib462","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(08)60268-8","article-title":"Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial","volume":"371","author":"Di Mario","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib463","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa0808276","article-title":"Routine early angioplasty after fibrinolysis for acute myocardial infarction","volume":"360","author":"Cantor","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib464","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jacc.2009.08.007","volume":"55","author":"Bohmer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib465","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMoa050849","article-title":"Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction","volume":"353","author":"Gershlick","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib466","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacc.2003.12.059","article-title":"A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial","volume":"44","author":"Sutton","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib467","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2006.09.033","article-title":"Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction. A meta-analysis of randomized trials","volume":"49","author":"Wijeysundera","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib468","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jacc.2006.03.064","article-title":"Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy","volume":"48","author":"Collet","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib469","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/eurheartj\/ehq204","article-title":"Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis","volume":"31","author":"Borgia","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib470","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(04)17059-1","article-title":"Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial","volume":"364","author":"Fernandez-Aviles","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib471","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib472","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(01)01550-9","article-title":"ST segment resolution as a tool for assessing the efficacy of reperfusion therapy","volume":"38","author":"de Lemos","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib473","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/heart.84.2.149","article-title":"Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method","volume":"84","author":"Sutton","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib474","doi-asserted-by":"crossref","DOI":"10.1161\/HCV.0000000000000035","article-title":"An update on radial artery access and best practices for transradial coronary angiography and intervention in acute coronary syndrome: a scientific statement from the American Heart Association","volume":"11","author":"Mason","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib475","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.123.064521","article-title":"STREAM-2: half-dose tenecteplase or primary percutaneous coronary intervention in older patients with ST-segment-elevation myocardial infarction: a randomized, open-label trial","volume":"148","author":"Van de Werf","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib476","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/heartjnl-2015-307815","article-title":"Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis","volume":"101","author":"Abdel-Qadir","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib477","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015186","article-title":"Comparison of reperfusion strategies for ST-segment-elevation myocardial infarction: a multivariate network meta-analysis","volume":"9","author":"Fazel","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib478","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008059","article-title":"Pharmacoinvasive strategy versus primary percutaneous coronary intervention in ST-elevation myocardial infarction in clinical practice: insights from the Vital Heart Response Registry","volume":"12","author":"Bainey","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib479","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcin.2014.09.005","volume":"8","author":"Madan","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib480","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","article-title":"Facilitated PCI in patients with ST-elevation myocardial infarction","volume":"358","author":"Ellis","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib481","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib482","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","article-title":"Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib483","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Fragmin and Fast Revascularisation during Instability in Coronary artery disease Investigators","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib484","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.300.1.71","article-title":"Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis","volume":"300","author":"O'Donoghue","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib485","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1001\/jama.293.23.2908","article-title":"Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib486","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib487","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"de Winter","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib488","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(17)31490-3","article-title":"Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials","volume":"390","author":"Jobs","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib489","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jjcc.2019.03.006","article-title":"Early versus delayed invasive strategy in patients with non-ST-elevation acute coronary syndrome and concomitant congestive heart failure","volume":"74","author":"Yoshida","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib490","first-page":"1177","article-title":"Proposed new classification for acute coronary syndrome: acute coronary syndrome requiring immediate reperfusion","volume":"101","author":"Zoni","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib491","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib492","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/CIRCULATIONAHA.118.037152","article-title":"Early versus standard care invasive examination and treatment of patients with non-ST-segment elevation acute coronary syndrome verdict randomized controlled trial","volume":"138","author":"Kofoed","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib493","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0735-1097(99)00126-6","volume":"33","author":"Scanlon","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib494","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjcard.2016.11.005","article-title":"Meta-analysis of randomized trials of long-term all-cause mortality in patients with non-ST-elevation acute coronary syndrome managed with routine invasive versus selective invasive strategies","volume":"119","author":"Elgendy","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib495","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.carrev.2019.10.004","article-title":"Timing of percutaneous coronary intervention in non-ST elevation acute coronary syndrome: meta-analysis and systematic review of literature","volume":"21","author":"Awan","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib496","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1093\/eurheartj\/ehac213","article-title":"Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"43","author":"Kite","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib497","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib498","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib499","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(18)31714-8","article-title":"Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial","volume":"392","author":"Valgimigli","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib500","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacc.2013.08.1651","article-title":"ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial","volume":"63","author":"Bernat","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib501","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/CIRCULATIONAHA.122.061527","article-title":"Effects on mortality and major bleeding of radial versus femoral artery access for coronary angiography or percutaneous coronary intervention: meta-analysis of individual patient data from 7 multicenter randomized clinical trials","volume":"146","author":"Gargiulo","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib502","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/M15-1277","article-title":"Radial versus femoral access in invasively managed patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"163","author":"And\u00f2","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib503","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jcin.2015.12.008","article-title":"Radial access reduces mortality in patients with acute coronary syndromes: results from an updated trial sequential analysis of randomized trials","volume":"9","author":"And\u00f2","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib504","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial","volume":"385","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib505","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib506","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2016.12.005","article-title":"Trends in U.S. cardiovascular care: 2016 report from 4 ACC national cardiovascular data registries","volume":"69","author":"Masoudi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib507","first-page":"17","article-title":"Patient preference for radial versus femoral vascular access for elective coronary procedures: the PREVAS study","volume":"91","author":"Kok","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib508","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2020.8228","article-title":"Association of radial artery graft vs saphenous vein graft with long-term cardiovascular outcomes among patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis","volume":"324","author":"Gaudino","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib509","first-page":"857","article-title":"Transulnar versus transradial access for coronary angiography or percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"87","author":"Dahal","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib510","first-page":"176","article-title":"Distal trans-radial access compared to conventional trans-radial access in coronary interventions: a meta-analysis","volume":"21","author":"Talha","year":"2022","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib511","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamacardio.2022.3399","article-title":"Routine ultrasonography guidance for femoral vascular access for cardiac procedures: the UNIVERSAL randomized clinical trial","volume":"7","author":"Jolly","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib512","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcin.2016.04.014","article-title":"Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials","volume":"9","author":"Ferrante","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib513","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamacardio.2019.4852","article-title":"Safety and efficacy of femoral access vs radial access in ST-segment elevation myocardial infarction: the SAFARI-STEMI randomized clinical trial","volume":"5","author":"Le May","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib514","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","article-title":"Thrombus aspiration during ST-segment elevation myocardial infarction","volume":"369","author":"Frobert","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib515","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","article-title":"Randomized trial of primary PCI with or without routine manual thrombectomy","volume":"372","author":"Jolly","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib516","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.116.025371","article-title":"Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: Thrombectomy Trialists Collaboration","volume":"135","author":"Jolly","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib517","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.2012.421","article-title":"Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial","volume":"307","author":"Stone","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib518","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib519","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1053\/euhj.2001.3035","article-title":"Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction","volume":"23","author":"Henriques","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib520","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0735-1097(01)01779-X","article-title":"Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction","volume":"39","author":"Stone","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib521","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2010.07.024","article-title":"Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial)","volume":"160","author":"Dudek","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib522","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2008.10.017","volume":"53","author":"Sardella","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib523","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0706416","article-title":"Thrombus aspiration during primary percutaneous coronary intervention","volume":"358","author":"Svilaas","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib524","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(08)60833-8","article-title":"Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study","volume":"371","author":"Vlaar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib525","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(15)00448-1","article-title":"Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial","volume":"387","author":"Jolly","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jacc.2024.11.009_bib526","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1405707","article-title":"Outcomes 1 year after thrombus aspiration for myocardial infarction","volume":"371","author":"Lagerqvist","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib527","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","article-title":"Intravascular imaging-guided or angiography-guided complex PCI","volume":"388","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib528","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMoa2305861","article-title":"Optical coherence tomography-guided versus angiography-guided PCI","volume":"389","author":"Ali","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib529","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcin.2019.09.033","article-title":"Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial","volume":"13","author":"Hong","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib530","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa2307770","article-title":"OCT or angiography guidance for PCI in complex bifurcation lesions","volume":"389","author":"Holm","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib531","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2020.10.001","article-title":"3-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation","volume":"14","author":"Gao","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib532","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jacc.2023.10.017","article-title":"Guiding intervention for complex coronary lesions by optical coherence tomography or intravascular ultrasound","volume":"83","author":"Kang","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib533","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/S0140-6736(16)31922-5","article-title":"Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial","volume":"388","author":"Ali","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib534","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1093\/eurheartj\/ehx351","article-title":"Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results","volume":"38","author":"Kubo","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib535","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011004","article-title":"Optical coherence tomography versus intravascular ultrasound and angiography to guide percutaneous coronary interventions: the iSIGHT randomized trial","volume":"14","author":"Chamie","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib536","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009314","article-title":"Comparison between optical frequency domain imaging and intravascular ultrasound for percutaneous coronary intervention guidance in biolimus A9-eluting stent implantation: a randomized MISTIC-1 non-inferiority trial","volume":"13","author":"Muramatsu","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib537","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(23)02454-6","article-title":"Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis","volume":"403","author":"Stone","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib538","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib539","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4244\/EIJ-D-19-01003","article-title":"Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy","volume":"16","author":"Ladwiniec","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2024.11.009_bib540","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jcmg.2017.09.008","article-title":"IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal","volume":"10","author":"Maehara","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib541","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2022.11.045","article-title":"Intravascular imaging during percutaneous coronary intervention: JACC state-of-the-art review","volume":"81","author":"Truesdell","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib542","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jcmg.2015.08.013","article-title":"Clinical impact of OCT findings during PCI: the CLI-OPCI II study","volume":"8","author":"Prati","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.009_bib543","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.114.014704","article-title":"Incidence and clinical significance of poststent optical coherence tomography findings: one-year follow-up study from a multicenter registry","volume":"132","author":"Soeda","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib544","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/CIRCULATIONAHA.123.067583","article-title":"Coronary angiography, intravascular ultrasound, and optical coherence tomography for guiding of percutaneous coronary intervention: a systematic review and network meta-analysis","volume":"149","author":"Giacoppo","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib545","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib546","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial","volume":"65","author":"Gershlick","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib547","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamacardio.2020.1251","article-title":"Complete vs culprit-lesion-only revascularization for ST-segment elevation myocardial infarction: a systematic review and meta-analysis","volume":"5","author":"Bainey","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib548","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstrom","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib549","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/14628840310030441","article-title":"Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study","volume":"6","author":"Di Mario","year":"2004","journal-title":"Int J Cardiovasc Intervent"},{"key":"10.1016\/j.jacc.2024.11.009_bib550","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/hrt.2009.177162","article-title":"A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up","volume":"96","author":"Politi","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib551","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Fractional flow reserve-guided multivessel angioplasty in myocardial infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib552","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib553","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jamacardio.2022.3032","article-title":"Complete revascularization vs culprit lesion-only percutaneous coronary intervention for angina-related quality of life in patients with ST-segment Elevation myocardial infarction: results from the COMPLETE randomized clinical trial","volume":"7","author":"Mehta","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib554","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(23)00351-3","article-title":"Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial","volume":"401","author":"Diletti","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib555","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa2307823","article-title":"Timing of complete revascularization with multivessel PCI for myocardial infarction","volume":"389","author":"Stahli","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib556","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013737","article-title":"Culprit-only revascularization, single-setting complete revascularization, and staged complete revascularization in acute myocardial infarction: insights from a mixed treatment comparison meta-analysis of randomized trials","volume":"17","author":"Maqsood","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib557","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib558","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","article-title":"One-year outcomes after PCI strategies in cardiogenic shock","volume":"379","author":"Thiele","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib559","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005582","article-title":"Culprit vessel-only versus multivessel percutaneous coronary intervention in patients with cardiogenic shock complicating ST-segment-elevation myocardial infarction: a collaborative meta-analysis","volume":"10","author":"Kolte","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib560","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib561","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMoa2104650","article-title":"Multivessel PCI guided by FFR or angiography for myocardial infarction","volume":"385","author":"Puymirat","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib562","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/eurheartj\/ehac763","article-title":"Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib563","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jacc.2024.04.051","article-title":"Percutaneous coronary revascularization strategies after myocardial infarction: a systematic review and network meta-analysis","volume":"84","author":"Reddy","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib564","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib565","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib566","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib567","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial","volume":"129","author":"Morice","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib568","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib569","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2300468","article-title":"Complete or culprit-only PCI in older patients with myocardial infarction","volume":"389","author":"Biscaglia","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib570","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jacc.2018.07.089","article-title":"Complete versus culprit-only lesion intervention in patients with acute coronary syndromes","volume":"72","author":"Rathod","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib571","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.amjcard.2019.07.071","article-title":"Meta-analysis comparing multivessel versus culprit coronary arterial revascularization for patients with non-ST-segment elevation acute coronary syndromes","volume":"124","author":"Siebert","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib572","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jacc.2015.10.082","article-title":"Single-staged compared with multi-staged PCI in multivessel NSTEMI patients: the SMILE trial","volume":"67","author":"Sardella","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib573","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(23)00351-3","article-title":"Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial","volume":"401","author":"Diletti","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib574","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jacc.2024.04.051","article-title":"Percutaneous coronary revascularization strategies after myocardial infarction: a systematic review and network meta-analysis","volume":"84","author":"Reddy","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib576","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jcin.2011.08.008","article-title":"Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study","volume":"4","author":"Sels","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib577","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehu338","article-title":"Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial","volume":"36","author":"Layland","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib578","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/eurheartj\/ehac763","article-title":"Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib579","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib580","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","article-title":"One-year outcomes after PCI strategies in cardiogenic shock","volume":"379","author":"Thiele","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib581","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib582","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007305","article-title":"Identifying the infarct-related artery in patients with non-ST-segment-elevation myocardial infarction","volume":"12","author":"Heitner","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib583","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ahj.2007.09.007","article-title":"Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report","volume":"155","author":"Brener","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib584","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0735-1097(02)02049-1","article-title":"Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization","volume":"40","author":"Hanratty","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib585","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004296","volume":"10","author":"Van Belle","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib586","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib587","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(21)02334-5","article-title":"Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis","volume":"398","author":"Sabatine","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib588","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib589","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib590","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcin.2010.01.012","volume":"3","author":"Parikh","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib591","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.115.015279","article-title":"Does timing of coronary artery bypass surgery affect early and long-term outcomes in patients with non-ST-segment-elevation myocardial infarction?","volume":"132","author":"Davierwala","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib592","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.athoracsur.2016.05.116","article-title":"Optimal timing from myocardial infarction to coronary artery bypass grafting on hospital mortality","volume":"103","author":"Nichols","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib593","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jcin.2024.01.278","article-title":"Timing of complete multivessel revascularization in patients presenting with non-ST-segment elevation acute coronary syndrome","volume":"17","author":"Elscot","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib595","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehy004","article-title":"Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial","volume":"39","author":"Scholz","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib596","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib597","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/ejcts\/ezv388","article-title":"Is emergency and salvage coronary artery bypass grafting justified? The Nordic emergency\/salvage coronary artery bypass grafting study","volume":"49","author":"Axelsson","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib598","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012049","article-title":"Early clinical outcomes of surgical myocardial revascularization for acute coronary syndromes complicated by cardiogenic shock: a report from the North-Rhine-Westphalia Surgical Myocardial Infarction Registry","volume":"8","author":"Liakopoulos","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib599","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib600","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","article-title":"One-year outcomes after PCI strategies in cardiogenic shock","volume":"379","author":"Thiele","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib601","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005582","article-title":"Culprit vessel-only versus multivessel percutaneous coronary intervention in patients with cardiogenic shock complicating ST-segment-elevation myocardial infarction: a collaborative meta-analysis","volume":"10","author":"Kolte","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib602","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib603","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2009.10.035","article-title":"Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?","volume":"159","author":"Mehta","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib604","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","article-title":"One-year survival following early revascularization for cardiogenic shock","volume":"285","author":"Hochman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib605","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib606","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ahj.2020.01.020","article-title":"Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock","volume":"226","author":"Smilowitz","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib607","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"Moller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib608","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcin.2021.02.046","article-title":"Mechanical circulatory support as a bridge to definitive treatment in post-infarction ventricular septal rupture","volume":"14","author":"Ronco","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib609","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/icvts\/ivaa108","article-title":"The use of extracorporeal membrane oxygenation in the setting of postinfarction mechanical complications: outcome analysis of the Extracorporeal Life Support Organization Registry","volume":"31","author":"Matteucci","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib610","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jcin.2019.04.039","article-title":"Temporal trends and outcomes of mechanical complications in patients with acute myocardial infarction","volume":"12","author":"Elbadawi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib611","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib612","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib613","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCULATIONAHA.118.038201","article-title":"Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial","volume":"139","author":"Thiele","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib614","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib615","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib616","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ejhf.1566","article-title":"Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study","volume":"21","author":"Helgestad","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.11.009_bib617","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic shock classification to predict mortality in the cardiac intensive care unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib618","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock","volume":"323","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib619","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamainternmed.2022.2735","article-title":"Clinical outcomes and cost associated with an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump in patients presenting with acute myocardial infarction complicated by cardiogenic shock","volume":"182","author":"Miller","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib620","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.acvd.2019.10.005","article-title":"Mechanical circulatory support with the Impella\u00ae LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: the IMPELLA-STIC randomized study","volume":"113","author":"Bochaton","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2024.11.009_bib621","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jacc.2016.10.026","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump for treating cardiogenic shock: meta-analysis","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib622","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib623","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcin.2010.04.015","article-title":"Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial)","volume":"3","author":"Seto","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib624","first-page":"318","article-title":"Ultrasound-guided catheterization of the femoral artery: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Sobolev","year":"2015","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib625","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamacardio.2022.3399","article-title":"Routine ultrasonography guidance for femoral vascular access for cardiac procedures: the UNIVERSAL randomized clinical trial","volume":"7","author":"Jolly","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib626","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib627","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(23)01607-0","article-title":"Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials","volume":"402","author":"Zeymer","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib628","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcin.2021.02.046","article-title":"Mechanical circulatory support as a bridge to definitive treatment in post-infarction ventricular septal rupture","volume":"14","author":"Ronco","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib629","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/icvts\/ivaa108","article-title":"The use of extracorporeal membrane oxygenation in the setting of postinfarction mechanical complications: outcome analysis of the Extracorporeal Life Support Organization Registry","volume":"31","author":"Matteucci","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib630","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jcin.2019.04.039","article-title":"Temporal trends and outcomes of mechanical complications in patients with acute myocardial infarction","volume":"12","author":"Elbadawi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib631","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjcard.2009.08.653","article-title":"Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI)","volume":"105","author":"French","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib632","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9149(92)91266-7","article-title":"Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention","volume":"70","author":"Lemery","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib633","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.101.1.27","article-title":"Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators","volume":"101","author":"Crenshaw","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib634","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.athoracsur.2020.03.097","article-title":"Mitral valve surgery for papillary muscle rupture: outcomes in 1342 patients from the Society of Thoracic Surgeons database","volume":"110","author":"Kilic","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib635","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/acs-2021-ami-10","article-title":"Surgical repair of post-infarction ventricular free-wall rupture in the Netherlands: data from a nationwide registry","volume":"11","author":"Matteucci","year":"2022","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib636","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0735-1097(00)00878-0","article-title":"Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries in cardiogenic shock?","volume":"36","author":"Menon","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib637","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/eurheartj\/ehu248","article-title":"Ventricular septal rupture complicating acute myocardial infarction: a contemporary review","volume":"35","author":"Jones","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib638","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1253\/circj.CJ-19-0593","article-title":"Surgical repair of post-infarction ventricular septal defect- findings from a Japanese national database","volume":"83","author":"Sakaguchi","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2024.11.009_bib639","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.athoracsur.2012.04.020","article-title":"Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database","volume":"94","author":"Arnaoutakis","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib640","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/icvts\/ivaa185","article-title":"Delayed surgery after mechanical circulatory support for ventricular septal rupture with cardiogenic shock","volume":"31","author":"Morimura","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jacc.2024.11.009_bib641","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1536\/ihj.21-581","article-title":"Benefits and risks of delayed surgery for ventricular septal rupture after acute myocardial infarction","volume":"63","author":"Furui","year":"2022","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib642","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4244\/EIJV12I1A17","article-title":"Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence","volume":"12","author":"Schlotter","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2024.11.009_bib643","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1093\/eurheartj\/ehac511","article-title":"Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry","volume":"43","author":"Giblett","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib644","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10741-021-10161-2","article-title":"Transition to heart transplantation in post-myocardial infarction ventricular septal rupture: a systematic review","volume":"28","author":"Perez-Villa","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2024.11.009_bib645","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/CIR.0b013e31826890b0","article-title":"Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association","volume":"126","author":"Morrow","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib646","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacc.2021.07.044","article-title":"Management and outcomes of cardiogenic shock in cardiac ICUs with versus without shock teams","volume":"78","author":"Papolos","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib647","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jacc.2018.12.084","article-title":"Standardized team-based care for cardiogenic shock","volume":"73","author":"Tehrani","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib648","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0735-1097(00)00845-7","article-title":"Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?","volume":"36","author":"Slater","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib649","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0735-1097(00)00846-9","article-title":"Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we use emergently revascularize occluded coronaries in cardiogenic shock?","volume":"36","author":"Thompson","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib650","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005050","article-title":"Acute mitral regurgitation secondary to papillary muscle tear: is transcatheter edge-to-edge mitral valve repair a new paradigm?","volume":"10","author":"Valle","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib651","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9149(03)00665-9","article-title":"Short and long-term hemodynamic effects of intra-aortic balloon support in ventricular septal defect complicating acute myocardial infarction","volume":"92","author":"Thiele","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib652","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","article-title":"Mechanical complications of acute myocardial infarction: a scientific statement from the American Heart Association","volume":"144","author":"Damluji","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib654","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib655","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib656","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib657","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib658","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","article-title":"Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib659","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.108.836791","article-title":"Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"120","author":"Zaman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib660","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","article-title":"Wearable cardioverter-defibrillator after myocardial infarction","volume":"379","author":"Olgin","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib661","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.amjcard.2014.08.038","article-title":"Influence of second-and third-degree heart block on 30-day outcome following acute myocardial infarction in the drug-eluting stent era","volume":"114","author":"Kim","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib662","doi-asserted-by":"crossref","first-page":"179","DOI":"10.31083\/j.rcm2406179","article-title":"Prognostic value of temporary pacemaker insertion in patients with acute myocardial infarction in the era of percutaneous coronary revascularization","volume":"24","author":"Wang","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib663","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib664","first-page":"616","article-title":"Risk of arrhythmias after myocardial infarction in patients with left ventricular systolic dysfunction according to mode of revascularization: a Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction (CARISMA) substudy","volume":"23","author":"Thomsen","year":"2021","journal-title":"EP: Europace"},{"key":"10.1016\/j.jacc.2024.11.009_bib665","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.10288","article-title":"Ventricular arrhythmias after primary percutaneous coronary intervention for STEMI","volume":"7","author":"Rymer","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2024.11.009_bib666","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJM200006293422602","article-title":"Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators","volume":"342","author":"Buxton","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib667","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","article-title":"CABG Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators","volume":"337","author":"Bigger","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib668","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter\u2013defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib669","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib670","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2017.12.036","article-title":"Prognostic significance of complex ventricular arrhythmias complicating ST-segment elevation myocardial infarction","volume":"121","author":"Podolecki","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib671","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials","volume":"64","author":"Kusumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib672","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.118.037997","article-title":"Catheter ablation of refractory ventricular fibrillation storm after myocardial infarction","volume":"139","author":"Komatsu","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib673","first-page":"e382","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib674","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jce.14404","article-title":"Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: as-treated and per-protocol analyses","volume":"31","author":"Olgin","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib675","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4070\/kcj.2016.46.3.315","article-title":"Differential clinical implications of high-degree atrioventricular block complicating ST-segment elevation myocardial infarction according to the location of infarction in the era of primary percutaneous coronary intervention","volume":"46","author":"Kim","year":"2016","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jacc.2024.11.009_bib676","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/heartjnl-2015-308260","article-title":"High-degree atrioventricular block complicating ST segment elevation myocardial infarction in the contemporary era","volume":"102","author":"Auffret","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib677","first-page":"218","article-title":"Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcome","volume":"7","author":"Aguiar Rosa","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib678","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/europace\/eus161","article-title":"High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention","volume":"14","author":"Gang","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.009_bib679","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jelectrocard.2018.03.003","article-title":"High-grade atrioventricular block in patients with acute myocardial infarction. Insights from a contemporary multi-center survey","volume":"51","author":"Alnsasra","year":"2018","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib680","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/eurheartj\/ehu357","article-title":"High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events","volume":"36","author":"Singh","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib681","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ahj.2015.09.004","article-title":"High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction","volume":"171","author":"Pokorney","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib682","doi-asserted-by":"crossref","unstructured":"Hynes JK, Holmes Jr DR, Harrison CE. Five-year experience with temporary pacemaker therapy in the coronary care unit. Mayo Clin Proc. 1983;58:122-126.","DOI":"10.1016\/S0025-6196(25)18727-2"},{"key":"10.1016\/j.jacc.2024.11.009_bib683","doi-asserted-by":"crossref","first-page":"784.e781","DOI":"10.1016\/j.amjmed.2015.01.040","article-title":"Etiology of pericarditis in a prospective cohort of 1162 cases","volume":"128","author":"Gouriet","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib684","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.amjcard.2011.06.025","article-title":"Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome","volume":"108","author":"Imazio","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib685","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.amjcard.2009.01.366","article-title":"Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention","volume":"103","author":"Imazio","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib686","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0002-8703(81)90610-4","article-title":"Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolution","volume":"101","author":"Berman","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib687","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib688","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib689","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib690","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib691","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib692","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-152-3-201002020-00004","article-title":"Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: a multicenter randomized, double-blind trial","volume":"152","author":"Meurin","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib693","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1136\/heartjnl-2015-307827","article-title":"Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomised controlled trial","volume":"101","author":"Meurin","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib694","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0002-9343(74)90603-2","article-title":"Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm","volume":"56","author":"Bulkley","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib695","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9149(87)90817-4","article-title":"Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction","volume":"59","author":"Silverman","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib696","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jacc.2022.01.011","article-title":"Left ventricular thrombus following acute myocardial infarction: JACC state-of-the-art review","volume":"79","author":"Camaj","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib697","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12968-018-0494-3","article-title":"Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis","volume":"20","author":"Bulluck","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2024.11.009_bib698","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib699","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/ehjcvp\/pvaa066","article-title":"Left ventricular thrombosis: new perspectives on an old problem","volume":"7","author":"Massussi","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2024.11.009_bib700","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jcmg.2016.12.006","article-title":"Timing of cardiac magnetic resonance imaging impacts on the detection rate of left ventricular thrombus after myocardial infarction","volume":"10","author":"Gellen","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.009_bib701","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib702","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.hrtlng.2013.07.010","article-title":"Arrhythmias in patients with acute coronary syndrome in the first 24 hours of hospitalization","volume":"42","author":"Winkler","year":"2013","journal-title":"Heart Lung"},{"key":"10.1016\/j.jacc.2024.11.009_bib703","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004635","article-title":"Predicting length of stay and the need for postacute care after acute myocardial infarction to improve healthcare efficiency","volume":"11","author":"Wasfy","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib704","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008894","article-title":"Risk score to predict need for intensive care in initially hemodynamically stable adults with non-ST-segment-elevation myocardial infarction","volume":"7","author":"Fanaroff","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib705","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1056\/NEJMoa2307983","article-title":"Restrictive or liberal transfusion strategy in myocardial infarction and anemia","volume":"389","author":"Carson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib706","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejim.2018.12.004","article-title":"Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome","volume":"61","author":"Vicente-Ibarra","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib707","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amjcard.2011.09.046","article-title":"Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes","volume":"109","author":"Younge","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib708","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.amjcard.2017.02.052","volume":"119","author":"Brener","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib709","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/2013.jamainternmed.1001","article-title":"Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis","volume":"173","author":"Chatterjee","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib710","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.292.13.1555","article-title":"Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes","volume":"292","author":"Rao","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib711","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ahj.2008.01.009","article-title":"Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes","volume":"155","author":"Alexander","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib712","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2005.06.072","article-title":"The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative","volume":"46","author":"Yang","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib713","first-page":"CD002042","article-title":"Transfusion thresholds for guiding red blood cell transfusion","volume":"12","author":"Carson","year":"2021","journal-title":"Cochrane Database Sys Review"},{"key":"10.1016\/j.jacc.2024.11.009_bib714","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.2023.12914","article-title":"Red blood cell transfusion: 2023 AABB international guidelines","volume":"330","author":"Carson","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib715","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ahj.2018.04.007","article-title":"Clinical trials evaluating red blood cell transfusion thresholds: an updated systematic review and with additional focus on patients with cardiovascular disease","volume":"200","author":"Carson","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib716","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jama.2021.0135","article-title":"Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial","volume":"325","author":"Ducrocq","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib717","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCULATIONAHA.121.057909","article-title":"One-year major cardiovascular events after restrictive versus liberal blood transfusion strategy in patients with acute myocardial infarction and anemia: the REALITY randomized trial","volume":"145","author":"Gonzalez-Juanatey","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib718","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/CIRCULATIONAHA.111.071860","article-title":"Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes","volume":"126","author":"Piccini","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib719","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.10288","article-title":"Ventricular arrhythmias after primary percutaneous coronary intervention for STEMI","volume":"7","author":"Rymer","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2024.11.009_bib720","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1161\/01.CIR.0000131765.73959.87","article-title":"Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib721","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004635","article-title":"Predicting length of stay and the need for postacute care after acute myocardial infarction to improve healthcare efficiency","volume":"11","author":"Wasfy","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib722","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/heartjnl-2012-302414","article-title":"Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction","volume":"98","author":"Jones","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib723","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1177\/2047487314559276","article-title":"Safety and health status following early discharge in patients with acute myocardial infarction treated with primary PCI: a randomized trial","volume":"22","author":"Melberg","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib724","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0735-1097(98)00031-X","article-title":"Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction","volume":"31","author":"Grines","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib725","first-page":"717","article-title":"Length of stay following percutaneous coronary intervention: an expert consensus document update from the society for cardiovascular angiography and interventions","volume":"92","author":"Seto","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.11.009_bib726","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ahj.2021.12.015","article-title":"Same day discharge following non-elective PCI for non-ST elevation acute coronary syndromes","volume":"246","author":"Hariri","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib727","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mhl.2003.11","article-title":"Transient myocardial ischemia is an independent predictor of adverse in-hospital outcomes in patients with acute coronary syndromes treated in the telemetry unit","volume":"32","author":"Pelter","year":"2003","journal-title":"Heart Lung"},{"key":"10.1016\/j.jacc.2024.11.009_bib728","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/eurheartj\/ehl100","article-title":"Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment","volume":"27","author":"Rahimi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib729","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jelectrocard.2009.12.010","article-title":"Ischemic ST-segment episodes during the initial 24 hours of ST elevation myocardial infarction predict prognosis at 1 and 5 years","volume":"43","author":"Ottander","year":"2010","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib730","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.amjcard.2013.05.069","article-title":"Evaluation of the appropriateness and outcome of in-hospital telemetry monitoring","volume":"112","author":"Falun","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib731","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1161\/CIR.0000000000000527","article-title":"Update to practice standards for electrocardiographic monitoring in hospital settings: a scientific statement from the American Heart Association","volume":"136","author":"Sandau","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib732","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2012.08.040","article-title":"Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus \u2265 40% (from the HORIZONS-AMI trial)","volume":"111","author":"Daneault","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib733","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/echo.12452","article-title":"Incremental value of left ventricular systolic and diastolic function to determine outcome in patients with acute ST-segment elevation myocardial infarction: the echocardiographic substudy of the OASIS-6 trial","volume":"31","author":"Dokainish","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.jacc.2024.11.009_bib734","first-page":"67","article-title":"The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial","volume":"3","author":"Ng","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2024.11.009_bib735","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","article-title":"Mechanical complications of acute myocardial infarction: a scientific statement from the American Heart Association","volume":"144","author":"Damluji","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib736","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib737","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC Scientific Expert Panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib738","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006428","article-title":"Prognostic stratification of patients with ST-segment-elevation myocardial infarction (PROSPECT): a cardiac magnetic resonance study","volume":"10","author":"Pontone","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.009_bib739","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/CIRCULATIONAHA.117.030693","article-title":"Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions","volume":"137","author":"Bulluck","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib740","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib741","doi-asserted-by":"crossref","first-page":"309","DOI":"10.11124\/JBISRIR-D-19-00042","article-title":"Effectiveness of discharge education strategies versus usual care on clinical outcomes in acute coronary syndrome patients: a systematic review","volume":"18","author":"Kourbelis","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.jacc.2024.11.009_bib742","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.pec.2020.12.001","article-title":"Education interventions in Chinese cardiac patients on health behaviours, disease-related knowledge, and health outcomes: a systematic review and meta-analysis","volume":"104","author":"Feng","year":"2021","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacc.2024.11.009_bib743","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1111\/jocn.16519","article-title":"Systematic review, meta-analysis and meta-regression to determine the effects of patient education on health behaviour change in adults diagnosed with coronary heart disease","volume":"32","author":"Shi","year":"2023","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.jacc.2024.11.009_bib744","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001939","article-title":"Medication-taking for secondary prevention of acute myocardial infarction: a thematic meta-synthesis of patient experiences","volume":"9","author":"Piekarz","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib746","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/CIRCULATIONAHA.116.024993","article-title":"Sex differences in 1-year all-cause rehospitalization in patients after acute myocardial infarction: a prospective observational study","volume":"135","author":"Dreyer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib747","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.amjcard.2017.06.046","article-title":"Comparison of 30-day readmission rates after hospitalization for acute myocardial infarction in men versus women","volume":"120","author":"O'Brien","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib748","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5195\/ijms.2022.1058","article-title":"Predictors of early (0-7 days) and late (8-30 days) readmission in a cohort of acute coronary syndrome patients","volume":"10","author":"Cholack","year":"2022","journal-title":"Int J Med Stud"},{"key":"10.1016\/j.jacc.2024.11.009_bib749","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s11886-022-01702-8","article-title":"Readmission after ACS: burden, epidemiology, and mitigation","volume":"24","author":"Boulos","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib750","first-page":"42","article-title":"Readmission of patients with acute coronary syndrome and determinants","volume":"113","author":"Oliveira","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib751","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000522016","article-title":"Multimorbidity and readmissions in older people with acute coronary syndromes","volume":"147","author":"Gudnadottir","year":"2022","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2024.11.009_bib754","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-157-6-201209180-00004","article-title":"Transitional care after hospitalization for acute stroke or myocardial infarction: a systematic review","volume":"157","author":"Bettger","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib755","author":"Albert"},{"key":"10.1016\/j.jacc.2024.11.009_bib756","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ehjqcco\/qcac032","article-title":"Impact of multicomponent integrated care on mortality and hospitalization after acute coronary syndrome: a systematic review and meta-analysis","volume":"9","author":"Hoo","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib757","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib758","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","volume":"11","author":"Dibben","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2024.11.009_bib759","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib760","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012264","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","volume":"2016","author":"Anderson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2024.11.009_bib761","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/eurheartj\/ehac747","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis","volume":"44","author":"Dibben","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib762","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamacardio.2020.5218","article-title":"Effectiveness of home-based mobile guided cardiac rehabilitation as alternative strategy for nonparticipation in clinic-based cardiac rehabilitation among elderly patients in Europe: a randomized clinical trial","volume":"6","author":"Snoek","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib763","article-title":"Efficacy of phase II remote home rehabilitation in patients with acute myocardial infarction after percutaneous coronary intervention","volume":"2022","author":"Li","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.jacc.2024.11.009_bib764","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1136\/heartjnl-2019-316349","article-title":"Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial","volume":"106","author":"Campo","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib765","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005902","article-title":"Tracking cardiac rehabilitation participation and completion among Medicare beneficiaries to inform the efforts of a national initiative","volume":"13","author":"Ritchey","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib766","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","article-title":"Socioeconomic status and cardiovascular outcomes: challenges and interventions","volume":"137","author":"Schultz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib767","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1840894","article-title":"Cost-effectiveness of cardiac rehabilitation in patients with coronary artery disease: a meta-analysis","volume":"2019","author":"Takura","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jacc.2024.11.009_bib768","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tcm.2017.02.005","article-title":"The role of cardiac rehabilitation in patients with heart disease","volume":"27","author":"McMahon","year":"2017","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib769","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archinternmed.2010.501","article-title":"Effect of cardiac rehabilitation referral strategies on utilization rates: a prospective, controlled study","volume":"171","author":"Grace","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib770","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIR.0000000000000663","article-title":"Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology","volume":"140","author":"Thomas","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib771","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28720","article-title":"Comparison of home-based vs center-based cardiac rehabilitation in hospitalization, medication adherence, and risk factor control among patients with cardiovascular disease","volume":"5","author":"Nkonde-Price","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2024.11.009_bib772","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/2047487314561168","article-title":"Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: a systematic review and meta-analysis","volume":"22","author":"Huang","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib773","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ahj.2013.01.018","article-title":"Benefits and costs of intensive lifestyle modification programs for symptomatic coronary disease in Medicare beneficiaries","volume":"165","author":"Zeng","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib774","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11886-019-1104-1","article-title":"Intensive cardiac rehabilitation: an underutilized resource","volume":"21","author":"Freeman","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2024.11.009_bib776","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/HCR.0000000000000700","article-title":"Benefits of the first Pritikin outpatient intensive cardiac rehabilitation program","volume":"42","author":"Racette","year":"2022","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2024.11.009_bib777","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010131","article-title":"Intensive versus traditional cardiac rehabilitation: mortality and cardiovascular outcomes in a 2016\u20132020 retrospective Medicare cohort","volume":"16","author":"Husaini","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib778","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/heartjnl-2017-312832","article-title":"Cardiac rehabilitation and physical activity: systematic review and meta-analysis","volume":"104","author":"Dibben","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib779","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/eurheartj\/ehv111","article-title":"Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients","volume":"36","author":"de Vries","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib780","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9149(85)90357-1","article-title":"Early exercise training in patients older than age 65 years compared with that in younger patients after acute myocardial infarction or coronary artery bypass grafting","volume":"55","author":"Williams","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib781","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9149(99)80054-X","article-title":"Effects of cardiac rehabilitation programs on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in a large elderly cohort","volume":"76","author":"Lavie","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib782","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0735-1097(93)90176-2","article-title":"Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly","volume":"22","author":"Lavie","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib783","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/euhj.1999.1581","article-title":"Improved physical fitness and quality of life following training of elderly patients after acute coronary events. A 1 year follow-up randomized controlled study","volume":"20","author":"Stahle","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib784","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/CIRCULATIONAHA.117.029471","article-title":"Geographic variation in cardiac rehabilitation participation in Medicare and Veterans Affairs populations: opportunity for improvement","volume":"137","author":"Beatty","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib785","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008088","article-title":"Sex and racial disparities in cardiac rehabilitation referral at hospital discharge and gaps in long-term mortality","volume":"7","author":"Li","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib786","first-page":"CD007130","article-title":"Home-based versus centre-based cardiac rehabilitation","volume":"10","author":"McDonagh","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2024.11.009_bib787","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jacc.2014.10.059","article-title":"Cardiac rehabilitation and risk reduction: time to \u201crebrand and reinvigorate.\u201d","volume":"65","author":"Sandesara","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib788","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib789","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib790","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib791","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib792","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib793","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib794","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1093\/eurheartj\/ehaa670","article-title":"Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS","volume":"41","author":"Baber","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib795","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0140-6736(24)00473-2","article-title":"Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial","volume":"403","author":"Ge","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib796","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCULATIONAHA.123.066943","article-title":"Stopping aspirin within 1 month after stenting for ticagrelor monotherapy in acute coronary syndrome: the T-PASS randomized noninferiority trial","volume":"149","author":"Hong","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib797","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib798","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015560","article-title":"Efficacy and safety of ticagrelor monotherapy by clinical presentation: pre-specified analysis of the GLOBAL LEADERS trial","volume":"10","author":"Vranckx","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib799","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1111\/bcp.15478","article-title":"Protective effect of proton-pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: a systematic review and meta-analysis","volume":"88","author":"Ahn","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2024.11.009_bib800","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib801","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib802","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2019.04.041","article-title":"Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and\/or aspirin in a randomized, double-blind, placebo-controlled trial","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2024.11.009_bib803","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","article-title":"Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial","volume":"388","author":"Cayla","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib804","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","article-title":"A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI","volume":"381","author":"Claassens","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib805","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","article-title":"Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (Timing of Platelet Inhibition After Acute Coronary Syndrome) randomized study","volume":"38","author":"Cuisset","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib806","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(21)01445-8","article-title":"Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial","volume":"398","author":"Kim","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib807","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","article-title":"Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial","volume":"390","author":"Sibbing","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib808","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib809","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib810","first-page":"804","article-title":"Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial","volume":"38","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib811","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","article-title":"Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS","volume":"67","author":"Baber","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib812","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib813","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib814","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib815","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib816","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib817","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib818","doi-asserted-by":"crossref","first-page":"e990","DOI":"10.4244\/EIJ-D-19-00539","article-title":"Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)","volume":"15","author":"De Luca","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2024.11.009_bib819","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(18)30493-8","article-title":"6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial","volume":"391","author":"Hahn","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib820","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.90.1.61","article-title":"Persistent activation of coagulation mechanism in unstable angina and myocardial infarction","volume":"90","author":"Merlini","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib821","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib822","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib823","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jacc.2016.03.512","volume":"68","author":"Bittl","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib824","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib825","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCULATIONAHA.120.046251","article-title":"The safety and efficacy of aspirin discontinuation on a background of a P2Y12 inhibitor in patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"142","author":"O'Donoghue","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib826","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.123.067283","article-title":"Safety and efficacy of ticagrelor monotherapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: an individual patient data meta-analysis of TWILIGHT and TICO randomized trials","volume":"149","author":"Baber","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib827","article-title":"P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials","volume":"373","author":"Valgimigli","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.11.009_bib828","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2024.0133","article-title":"Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis","volume":"9","author":"Valgimigli","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib829","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehp159","article-title":"Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial","volume":"30","author":"Michelson","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib830","first-page":"1034","article-title":"Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients","volume":"38","author":"Palmerini","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib831","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.123.066720","article-title":"An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial","volume":"149","author":"Natsuaki","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib832","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib833","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH08-12-0808","article-title":"Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel","volume":"101","author":"Sibbing","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2024.11.009_bib834","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ahj.2016.01.015","article-title":"Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial","volume":"174","author":"Gargiulo","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib835","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials","volume":"374","author":"O'Donoghue","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib836","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.111.032912","article-title":"Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial","volume":"125","author":"Goodman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib837","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy","volume":"56","author":"Storey","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib838","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.123.064473","article-title":"Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the Academic Research Consortium","volume":"147","author":"Capodanno","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib839","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib840","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(21)00533-X","article-title":"Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"397","author":"Galli","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib841","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ehjcvp\/pvab068","article-title":"Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis","volume":"8","author":"Tavenier","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2024.11.009_bib842","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib843","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jacc.2022.07.016","article-title":"Abbreviated antiplatelet therapy after coronary stenting in patients with myocardial infarction at high bleeding risk","volume":"80","author":"Smits","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib844","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib845","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib846","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib847","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib848","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib849","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib850","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib851","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib852","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/eurheartj\/ehz732","volume":"40","author":"Gargiulo","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib853","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamacardio.2019.6175","article-title":"Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis","volume":"5","author":"Lopes","year":"2020","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.jacc.2024.11.009_bib854","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017212","article-title":"Safety and efficacy of double antithrombotic therapy with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"9","author":"Capodanno","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib855","doi-asserted-by":"crossref","first-page":"F50","DOI":"10.1093\/ehjcvp\/pvaa116","volume":"7","author":"Gargiulo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2024.11.009_bib856","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/europace\/euz345","volume":"22","author":"Galli","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2024.11.009_bib857","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.carrev.2021.05.013","article-title":"Antithrombotic therapy with or without aspirin after percutaneous coronary intervention or acute coronary syndrome in patients taking oral anticoagulation: a meta-analysis and network analysis of randomized controlled trials","volume":"36","author":"Colleran","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib858","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/CIRCULATIONAHA.120.046534","article-title":"Risk\/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS","volume":"141","author":"Alexander","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib859","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.119.044584","article-title":"Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial","volume":"141","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib860","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.121.056680","article-title":"Abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an open-label, randomized, controlled trial","volume":"144","author":"Smits","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib861","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.jacc.2024.11.009_bib862","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200422003-00003","article-title":"Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy","volume":"22","author":"Benner","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jacc.2024.11.009_bib863","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Cholesterol Treatment Trialists Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.11.009_bib864","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib865","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.amjcard.2019.04.017","article-title":"Adherence to blood cholesterol treatment guidelines among physicians managing patients with atherosclerotic cardiovascular disease","volume":"124","author":"Ramsaran","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib866","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008861","article-title":"Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 2015 and 2019","volume":"15","author":"Zheutlin","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.11.009_bib867","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/heartjnl-2020-318760","article-title":"Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges","volume":"107","author":"Packard","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.11.009_bib868","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","article-title":"Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy","volume":"46","author":"Wiviott","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib869","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jamacardio.2017.0083","article-title":"Long-term safety and efficacy of achieving very low levels of low-density lipoprotein cholesterol: a prespecified analysis of the IMPROVE-IT trial","volume":"2","author":"Giugliano","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib870","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jamacardio.2017.3944","article-title":"Clinical efficacy and safety of evolocumab in high-risk patients receiving a statin: secondary analysis of patients with low LDL cholesterol levels and in those already receiving a maximal-potency statin in a randomized clinical trial","volume":"2","author":"Giugliano","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib871","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib872","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009251","article-title":"Measurement of low-density lipoprotein cholesterol levels in primary and secondary prevention patients: insights from the PALM Registry","volume":"7","author":"Lowenstern","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib873","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ahj.2017.08.005","article-title":"Lipid management in contemporary community practice: results from the Provider Assessment of Lipid Management (PALM) Registry","volume":"193","author":"Navar","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib874","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib875","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib876","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib877","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib878","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib879","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib880","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib881","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib882","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.11.009_bib883","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib884","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib885","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib888","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2024.06.013","article-title":"2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"84","author":"Thompson","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib889","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300286","article-title":"Dapagliflozin in myocardial infarction without diabetes or heart failure","volume":"3","author":"James","year":"2024","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jacc.2024.11.009_bib890","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","article-title":"Empagliflozin after acute myocardial infarction","volume":"390","author":"Butler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib891","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib892","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib893","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib894","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2024.11.009_bib895","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib896","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2024.11.009_bib897","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib898","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10753-015-0237-7","article-title":"Effect of colchicine on platelet-platelet and platelet-leukocyte interactions: a pilot study in healthy subjects","volume":"39","author":"Shah","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.jacc.2024.11.009_bib899","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.11.009_bib900","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jacc.2024.11.009_bib901","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims","volume":"75","author":"Solomon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2024.11.009_bib902","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome","volume":"78","author":"Opstal","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.11.009_bib903","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"144","author":"Frobert","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.11.009_bib904","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","article-title":"Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study","volume":"25","author":"Gurfinkel","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib905","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib906","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","volume":"32","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib907","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/eurheartj\/ehm035","article-title":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects","volume":"28","author":"Madjid","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.11.009_bib908","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(09)70233-6","article-title":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review","volume":"9","author":"Warren-Gash","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jacc.2024.11.009_bib909","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2003.09.005","article-title":"Influenza: a trigger for acute myocardial infarction","volume":"172","author":"Dvorakova","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2024.11.009_bib910","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019636","article-title":"Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis","volume":"10","author":"Yedlapati","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.11.009_bib912","first-page":"28","article-title":"Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry","volume":"31","author":"Gurfinkel","year":"2004","journal-title":"Tex Heart Inst J"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2025.03.500","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000}},{"DOI":"10.1016\/j.jacc.2025.10.050","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000}}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972410424X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972410424X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:16:03Z","timestamp":1781093763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972410424X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":899,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S073510972410424X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.11.009","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation, and the American Heart Association, Inc.","name":"copyright","label":"Copyright"}]}}